Last $1.44 USD
Change Today +0.08 / 5.88%
Volume 3.0M
SNSS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 10/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel N. Swisher Jr.

Chief Executive Officer, President and Director, Sunesis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
51$1,892,441
As of Fiscal Year 2013

Background*

Mr. Daniel N. Swisher, Jr., also known as Dan, has been the Chief Executive Officer of Sunesis Pharmaceuticals Inc., since January 2004 and has been its President since August 2005. Mr. Swisher joined Sunesis Pharmaceuticals in January 2002 and served as its Chief Business Officer & Chief Financial Officer from December 2001 to December 2003. He served as Chief Operating Officer of Sunesis. He has more than 15 years of experience in pharmaceutical product development, ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

2004-Present
Chief Executive Officer, President and Director
2011-Present
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
Yale University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$469,875
Total Annual Compensation$469,875

Stock Options*

All Other Compensation$3,466
Exercised Options25,000
Exercised Options Value$62,750
Exercisable Options926,336
Exercisable Options Value$1,998,061
Unexercisable Options748,959
Unexercisable Options Value$1,435,940
Total Value of Options$3,496,750
Total Number of Options1,700,295

Total Compensation*

Total Annual Cash Compensation$734,591
Total Short Term Compensation$469,875
Other Long Term Compensation$3,466
Total Calculated Compensation$1,892,441
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNSS:US $1.44 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John R. Plachetka Pharm D.Co-Founder, Chairman, Chief Executive Officer and President
POZEN Inc.
$591.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.